Protecting kids from irreversible procedures

When fog rolls over a ridge, a good mountain guide stops. He keeps the group close, keeps them warm, talks them through the fear and waits until he can see the trail. He does not lead anyone toward an edge he cannot see.

In recent years, some American kids who felt their bodies did not match who they were have been offered puberty blockers, cross-sex hormones and sometimes surgery. These children are real, and their pain is real. Everyone involved wants to help them. The hard question is whether the most permanent kinds of help are safe for someone too young to weigh what they might lose.

What the evidence says

On Jan. 28, 2025, eight days into his term, President Trump signed an order directing federal agencies to cut off research and education grants to institutions that perform these procedures on anyone under 19, and asking HHS to review the evidence. That review, revised and peer reviewed in November 2025, rated the quality of the evidence very low and called the benefits very uncertain. The harms it lists include infertility and impaired bone development. On regret, it says plainly: “The true rate of regret is not known.” England got there first. Its Cass Review found the evidence weak, and in 2024 England's health service stopped prescribing puberty blockers to minors outside research trials.

Where things stand

In June 2025 the Supreme Court upheld Tennessee's ban, 6-3. Chief Justice John Roberts wrote, “The Equal Protection Clause does not resolve these disagreements,” leaving the question to voters and legislators while granting that both sides raise sincere concerns. KFF counts 25 state bans now in force. By STAT News' count, 42 hospitals and health systems paused or stopped some of this care for young people between January 2025 and early February 2026. A federal rule ending Medicaid and CHIP funding for these procedures on minors took effect Oct. 13, 2026. It gives children already on hormones up to six months of continued coverage and leaves mental health care untouched. More than 20 states sued over the rule on Sept. 2 in federal court in Massachusetts, asking a judge to throw it out. When I last checked, no court had blocked it, but I could not confirm its status after it took effect.

The strongest objection comes from families who say this care saved their child, and from American medical groups that have long supported it. I take them seriously. These parents love their children, and many doctors acted in good faith. Courts have pushed back too. A federal judge in Maryland blocked the order's funding cutoff in March 2025, and the appeal is still pending. Other judges have refused federal demands for patients' private records. A few hospitals resumed care after a pause.

But love is a reason to slow down, not to speed up. When the benefit is very uncertain and the cost may include a child's future fertility, the loving choice is to keep caring for the child while the evidence catches up. Counseling stays covered. Nothing in the federal rule tells a hurting teenager to face this alone.

A guide who waits for the fog to lift has not abandoned anyone. He is keeping every trail open until the child is old enough to choose one.